Human mesenchymal stem cells (hMSCs) secretome has been have been at the forefront of
a new wave of possible therapeutic strategies for central nervous system neurodegenerative …

Parkinson's disease (PD) is a common neurodegenerative disorder of the brain and typically
presents with a disorder of movement. The core pathological event underlying the condition …

Parkinson's disease (PD) is a chronic progressive neurodegenerative disorder
symptomatically characterized by resting tremor, rigidity, bradykinesia, and gait impairment …

Parkinson's disease (PD) is the second most common neurodegenerative disease,
manifesting as a characteristic movement disorder with a number of additional non-motor …

Research in the last decade strongly suggests that mesenchymal stem cell (MSC)-mediated
therapeutic benefits are mainly due to their secretome, which has been proposed as a …

This commentary highlights the major findings and future research directions arising from
the recent publication by Zuo and colleagues in Stem Cells 2017 (in press). Here, we …

Background: Parkinson's disease (PD) is the second most common neurodegenerative
disorder worldwide, the lifetime risk of developing this disease is 1.5%. Motor diagnostic …

Parkinson's disease (PD) is a neurodegenerative condition characterized by the loss of
midbrain dopaminergic neurons, leading to motor symptoms. While current treatments …

Mesenchymal stem cells have shown regenerative properties in many tissues. This feature
had originally been ascribed to their multipotency and thus their ability to differentiate into …

Parkinson's disease (PD) is a common neurodegenerative disorder of the brain and typically
presents with a disorder of movement. The core pathological event underlying the condition …